A61K 9/1629
Organic macromolecular compounds
Official title: {Organic macromolecular compounds}
A61K9/1629 (Organic macromolecular compounds) appears on 5,673 US grants and 9,318 published applications in this corpus.
Search patents in A61K- Granted patents
- 5,673
- Published applications
- 9,318
- Assignees
- 3,367
- Inventors
- 15,720
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 6 | 0 |
| 1979 | 6 | 0 |
| 1980 | 7 | 0 |
| 1981 | 5 | 0 |
| 1982 | 10 | 0 |
| 1983 | 12 | 0 |
| 1984 | 5 | 0 |
| 1985 | 11 | 0 |
| 1986 | 12 | 0 |
| 1987 | 25 | 0 |
| 1988 | 30 | 0 |
| 1989 | 42 | 0 |
| 1990 | 49 | 0 |
| 1991 | 42 | 0 |
| 1992 | 40 | 0 |
| 1993 | 36 | 0 |
| 1994 | 46 | 0 |
| 1995 | 72 | 0 |
| 1996 | 83 | 0 |
| 1997 | 101 | 0 |
| 1998 | 99 | 0 |
| 1999 | 121 | 0 |
| 2000 | 105 | 0 |
| 2001 | 134 | 66 |
| 2002 | 145 | 227 |
| 2003 | 169 | 314 |
| 2004 | 98 | 334 |
| 2005 | 82 | 329 |
| 2006 | 110 | 287 |
| 2007 | 68 | 324 |
| 2008 | 65 | 362 |
| 2009 | 69 | 331 |
| 2010 | 127 | 406 |
| 2011 | 119 | 348 |
| 2012 | 194 | 363 |
| 2013 | 251 | 370 |
| 2014 | 324 | 413 |
| 2015 | 265 | 419 |
| 2016 | 254 | 437 |
| 2017 | 288 | 483 |
| 2018 | 270 | 338 |
| 2019 | 236 | 393 |
| 2020 | 234 | 440 |
| 2021 | 231 | 457 |
| 2022 | 202 | 433 |
| 2023 | 203 | 437 |
| 2024 | 206 | 380 |
| 2025 | 220 | 337 |
| 2026 | 137 | 290 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Carotenoid preparations, preparation methods, and application thereof6 Oct 2026US 12,751,924 B2Innobio Corporation Limited
- Formulation for oral administration, comprising triazine derivative6 Oct 2026US 12,751,955 B2Shionogi & Co., Ltd.
- Formulation to deter abuse of drugs by smoking22 Sep 2026US 12,740,944 B2Purdue Research Foundation
- Pharmaceutical composition and method for enhancing solubility of poorly soluble active pharmaceutical ingredients15 Sep 2026US 12,734,130 B2Merck Patent GmbH
- Curcuminoid compositions15 Sep 2026US 12,734,135 B2Givaudan France Naturals SAS
- Hyaluronic acid hydrogels with agent to enhance resorption8 Oct 2026US 2026/0306398 A1Boston Scientific Scimed, Inc.
- Subcutaneous peptide delivery system8 Oct 2026US 2026/0306408 A1
- Drug-containing particle8 Oct 2026US 2026/0306409 A1Towa Pharmaceutical Co., Ltd.
- Moisture-proof acetyl l-carnitine8 Oct 2026US 2026/0306437 A1Nanjing Nutrabuilding Bio-Tech Co., Ltd.
- Oral pharmaceutical formulations containing 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives8 Oct 2026US 2026/0306514 A1Cadrenal Therapeutics, Inc.
Most cited
By later US patents
- Polyhydroxyalkanoate compositions having controlled degradation rates1,516US 6,867,248 B1Metabolix, Inc. · 2005
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Method for making a bioerodible material for the sustained release of a medicament and the material made from the method1,033US 5,456,917 ACambridge Scientific, Inc. · 1995
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers896US 5,410,016 ABoard of Regents, The University of Texas System · 1995